2nd ESO-ESSO Masterclass in Breast Cancer Surgery
30 ESCO credits
09.04.2016 - 12.04.2016
Lisbon, Portugal
MASTERCLASS
Description
Chairs: M.J. Cardoso, PT - M. Leidenius, FI - L. Wyld, UK
Scientific Coordinator: W. Gatzemeier, IT
The ESO-ESSO Masterclass will present the cutting edge of current concepts in surgical treatment of breast cancer. The programme will focus on evidenced-based clinical practice and technical aspects of breast cancer surgery, within a multidisciplinary setting. State-of-the-art lectures, workshops, case presentations and discussions will facilitate the interaction between participants and the faculty.
AIMS AND OBJECTIVES
The Masterclass in Breast Cancer Surgery offers participants a qualified, comprehensive training to improve their knowledge and skills in the management, treatment and care in the field of breast cancer.
Within the concept of a multidisciplinary approach attendees will increase their self confidence in the management of complex cases and will better understand current best clinical practice and state of the art in breast cancer care.
The Masterclass will enable participants to implement evidence-based concepts and guidelines on the surgical treatment of breast cancer to individualize the care of their patients.
TEACHING FORMAT
The Masterclass in Breast Cancer Surgery is at the cutting edge of current concepts of surgical treatment of breast cancer. The focus of the Masterclass is on evidence-based clinical practice and technical aspects of breast cancer surgery, within a multidisciplinary approach. The programme offers plenary lectures regarding state-of-the-art clinical evaluation and treatments with reference to clinical guidelines which will conclude in take-home messages. The clinical sessions will be complemented by Tumour Board discussions.
Furthermore, participants will deliver case presentations within small groups and discuss these with the chairmen and the faculty aiming at facilitating the interaction between participants and teachers.
All participants will reside at the course venue and participation is compulsory
throughout the course. The Masterclass will be entirely in English and fluency in English is mandatory for admission.
MAIN TOPICS
• Multidisciplinary team: Why it is crucial
• Screening, prevention and management of DCIS and other risk lesions
• Breast conservative treatment, mastectomy techniques, oncoplastic and reconstructive surgery
• Management of high-risk women and very young breast cancer patients
• Management of axillary nodes, status-quo and future developments
• What surgeons need to know about radiation oncology
LEARNING OBJECTIVES
• Improve knowledge and skills in the management, treatment and care in the field
• Update in the multidisciplinary approach
• Learn to treat breast cancer as a whole challenge
• Understand how to manage special situations
• Improve skills in implementing evidence-based concepts and guidelines in breast cancer surgery
THE MASTERCLASS IS:
• A 3-day residential educational event
• A full immersion in breast cancer surgery
• A clinically-oriented training
• Multidisciplinary
• Lead by an international faculty of top experts
• A programme including meet the expert workshops and case discussions
The 2nd Masterclass in |  | ||||
General information
ORGANISING SECRETARIAT
Ana Galán
Education Coordinator
European Society of Surgical Oncology (ESSO)
Avenue E. Mounier 83
1200 Brussels (Belgium)
e-mail: ana.galan@essoweb.org
Rita De Martini
European School of Oncology (ESO)
Via Turati, 29
20121 Milan (Italy)
e-mail: rdemartini@eso.net
ACCREDITATION
Participants will be entitled to receive a certificate of attendance at the close of the event by completing the on-line evaluation questionnaire.
The event has been accredited by the European Accreditation Council for Continuing Medical Education (EACCME) to provide the following CME activity for medical specialists. The EACCME is an institution of the European Union of Medical Specialists (UEMS). The evaluation of the event has been performed by the Accreditation Council of Oncology in Europe (ACOE) that acknowledged the quality of the scientific programme and its educational value.
The event is designated for a maximum of 17 European CME credits (ECMEC).
Through an agreement between UEMS and the American Medical Association, physicians may convert EACCME credits to an equivalent number of AMA PRA Category 1 Credits™.
Faculty list
FACULTY (as of October 2015)
F. Cardoso, Breast Unit, Champalimaud Cancer Center, Lisbon, PT
M.J. Cardoso, Breast Cancer Unit, Champalimaud Cancer Center, Lisbon, PT
W. Gatzemeier, Breast Unit, Humanitas Cancer Center, Rozzano/Milan, IT
T. Kovacs, Breast Unit, Guy's and St. Thomas' NHS Foundation Trust, London, UK
M. Leidenius, Breast Surgery Unit, Helsinki University Central Hospital, Helsinki, FI
P. Panizza, Department of Diagnostic Radiology 1, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, IT
F. Peccatori, Division of Ematoncology, Istituto Europeo di Oncologia, Milan, IT
G. Pruneri, Division of Pathology and Laboratory Medicine , European Institute of Oncology, Milan, IT
D. Rainsbury, Oncoplastic Breast Surgery, Royal Hampshire County Hospital, Winchester, UK
S. Suominen, Department of Plastic Surgery, Helsinki University Central Hospital, Helsinki, FI
M. Thill, Department of Gynecology and Obstetrics, Certified Breast Cancer Center, Agaplesion Markus, Frankfurt, DE
C. Vrieling, Clinique des Grangettes, Department of Radiation Oncology, Geneva, CH
L. Wyld, Academic Unit of Surgical Oncology, University of Sheffield Medical School, Sheffield, UK
Programme
9 April
| Morning: Participants' arrival, welcome coffee and registration | ||
| 14:15 | Warm-up session (3 groups with Chairs) | |
| 14:45 | Opening | |
| Multidisciplinary team of breast cancer: Why is it crucial? F. Cardoso, PT | ||
| Session 1: Screening - Prevention - Multidisciplinary management of DCIS and other high risk lesions | ||
15:05 | The role of the radiologist | |
15:25 | Classification and prognostic markers | |
15:45 | Surgical management of DCIS M. Leidenius, FI | |
16:05 | Radiation treatment of DCIS C. Vrieling, CH | |
| 16:25 | Coffee break | |
| Session 2: Microinvasive breast cancer and borderline lesions | ||
| 16:55 | Microinvasive breast cancer M. Leidenius, FI | |
| 17:15 | Pathology G. Pruneri, IT | |
| 17:35 | Tumour board: Sessions 1+2 (4 cases provided by participants and faculty) | |
| 18:30 | End of daily programme | |
| 19:30 | Welcome drink and Dinner at the Hotel | |
10 April
| Session 3: Breast conservative treatment (BCT) | ||
| 8:30 | Margins: What does really matter? M. Thill, DE | |
| 8:50 | Multifocal-multicentric disease and BCT | |
| 9:10 | Radiation treatment: Essentials in BCT | |
| 9:30 | Surgical treatment after recurrent breast cancer | |
| 10:00 | Coffee break | |
Session 4: Locally advanced, recurrent and advanced breast cancer | ||
| 10:30 | Primary systemic therapy F. Cardoso, PT | |
| 11:00 | Surgical considerations and primary systemic therapy W. Gatzemeier, IT | |
| 11:20 | Surgery in locally advanced breast cancer M.J. Cardoso, PT | |
| 11:50 | Primary site surgery in stage IV breast cancer W. Gatzemeier, IT | |
| 12:10 | Tumour board: Sessions 3+4 (3 cases provided by participants and faculty) | |
| 13:00 | Lunch | |
| Session 5a: Breast cancer in young patients | ||
| 14:00 | Surgery in young women - What is different L. Wyld, UK | |
| 14:20 | Medical treatment in young women - What is different F. Cardoso, PT | |
| Session 5b: Management of high risk women | ||
| 14:40 | High risk women L. Wyld, UK | |
| 15:10 | Tumour board: Session 5 (3 cases provided by participants and faculty) | |
| 16:00 | Coffee break | |
| 16:30 - Session 6: Workshop - Meet the expert 1 (small groups) case presentation (cases provided by participants) and pro/cons discussion | ||
| 18:30 -18:50 | Personalised medicine and genomic profiling M.Thill, DE | |
11 April
| Session 7: Oncoplastic surgery | ||
| 8:30 | Oncoplastic breast conservation: Indications, techniques and outcomes D. Rainsbury, UK | |
| 9:00 | Aesthetic outcome: NSH Audit/PROMS. Objective aesthetic outcome D. Rainsbury, UK - M.J. Cardoso, PT | |
| Session 8: Mastectomy | ||
| 9:15 | Skin sparing and non-skin sparing T. Kovacs, UK | |
| 9:35 | Nipple sparing L. Wyld, UK | |
| 10:00 | Coffee break | |
| 10:30 | Prophylactic - bilateral and contralateral L. Wyld, UK | |
| Session 9: Breast reconstruction | ||
| 10:50 | Critical review of implant reconstruction D. Rainsbury, UK | |
| 11:10 | Current practice for implant based breast reconstruction: The role of ADMS and dermal sling to improve outcomes and patient satisfaction T. Kovacs, UK | |
| 11:30 | Flaps S. Suominen, FI | |
| 11:50 | Postmastectomy radiotherapy and reconstruction C. Vrieling, CH | |
| 12:10 | Tumor board: Sessions 8+9 (3 cases provided by participants and faculty) | |
| 13:00 | Lunch | |
| Session 10: axillary management | ||
| 14:00 | SLNB before and after NACT T. Kovacs, UK | |
| 14:30 | Management of axillary lymph-node: status quo and future W. Gatzemeier, IT | |
| 15:00 | Axillary radiation treatment C. Vrieling, CH | |
| 15:30 | Nomograms M. Leidenius, FI | |
| 16:00 | Coffee break | |
| 16:15 | Tumour board: Session 10 | |
| 18:00 | Meeting in the Hotel Lobby for transfer | |
| 18:30 | Visit to Fundacao Champalimaud | |
| 19:30 | Social Dinner at a city Restaurant | |
12 April
| Session 11: Special situations | ||
| 8:30 | Fertility preservation F. Peccatori, IT | |
| 8:50 | Breast cancer in pregnancy F. Peccatori, IT | |
| 9:10 | Chronic pain M. Leidenius, FI | |
| 9:30 | Surgical treatment of lymphedema S. Suominen, FI | |
| 9:50 | Tumor board: Sessions 12 (1 cases provided by participants and faculty) | |
| 10:00 | Coffee break | |
| 10:30 | Learning assessment test | |
| 12:00 | Close | |
| Departure of participants | ||